209 related articles for article (PubMed ID: 29513752)
21. DNA Intercalation Facilitates Efficient DNA-Targeted Covalent Binding of Phenanthriplatin.
Almaqwashi AA; Zhou W; Naufer MN; Riddell IA; Yilmaz ÖH; Lippard SJ; Williams MC
J Am Chem Soc; 2019 Jan; 141(4):1537-1545. PubMed ID: 30599508
[TBL] [Abstract][Full Text] [Related]
22. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
[TBL] [Abstract][Full Text] [Related]
23. Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions.
Savino S; Marzano C; Gandin V; Hoeschele JD; Natile G; Margiotta N
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011897
[TBL] [Abstract][Full Text] [Related]
24. Effect of a monofunctional phenanthriplatin-DNA adduct on RNA polymerase II transcriptional fidelity and translesion synthesis.
Kellinger MW; Park GY; Chong J; Lippard SJ; Wang D
J Am Chem Soc; 2013 Sep; 135(35):13054-61. PubMed ID: 23927577
[TBL] [Abstract][Full Text] [Related]
25. Inversion of the cis geometry requirement for cytotoxicity in structurally novel platinum(II) complexes containing the bidentate N,O-donor pyridin-2-yl-acetate.
Bierbach U; Sabat M; Farrell N
Inorg Chem; 2000 May; 39(9):1882-90. PubMed ID: 11428108
[TBL] [Abstract][Full Text] [Related]
26. Mechanistic and biological characteristics of different sugar conjugated 2-methyl malonatoplatinum(II) complexes as new tumor targeting agents.
Gao X; Liu S; Shi Y; Huang Z; Mi Y; Mi Q; Yang J; Gao Q
Eur J Med Chem; 2017 Jan; 125():372-384. PubMed ID: 27688191
[TBL] [Abstract][Full Text] [Related]
27. Design, Synthesis, and Biological Features of Platinum(II) Complexes with Rigid Steric Hindrance.
Wang Z; Yu H; Gou S; Chen F; Fang L
Inorg Chem; 2016 May; 55(9):4519-28. PubMed ID: 27074104
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of series of diazine-bridged dinuclear platinum(II) complexes through in vitro toxicity and molecular modeling: correlation between structure and activity of Pt(II) complexes.
Senerovic L; Zivkovic MD; Veselinovic A; Pavic A; Djuran MI; Rajkovic S; Nikodinovic-Runic J
J Med Chem; 2015 Feb; 58(3):1442-51. PubMed ID: 25551180
[TBL] [Abstract][Full Text] [Related]
29. Effects of monofunctional platinum agents on bacterial growth: a retrospective study.
Johnstone TC; Alexander SM; Lin W; Lippard SJ
J Am Chem Soc; 2014 Jan; 136(1):116-8. PubMed ID: 24364388
[TBL] [Abstract][Full Text] [Related]
30. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
[TBL] [Abstract][Full Text] [Related]
31. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
[TBL] [Abstract][Full Text] [Related]
32. Spectrum of cellular responses to pyriplatin, a monofunctional cationic antineoplastic platinum(II) compound, in human cancer cells.
Lovejoy KS; Serova M; Bieche I; Emami S; D'Incalci M; Broggini M; Erba E; Gespach C; Cvitkovic E; Faivre S; Raymond E; Lippard SJ
Mol Cancer Ther; 2011 Sep; 10(9):1709-19. PubMed ID: 21750216
[TBL] [Abstract][Full Text] [Related]
33. A dinuclear monofunctional platinum(II) complex with an aromatic linker shows low reactivity towards glutathione but high DNA binding ability and antitumor activity.
Fan D; Yang X; Wang X; Zhang S; Mao J; Ding J; Lin L; Guo Z
J Biol Inorg Chem; 2007 Jun; 12(5):655-65. PubMed ID: 17334797
[TBL] [Abstract][Full Text] [Related]
34. The new antitumor compound, cis-[Pt(NH3)2(4-methylpyridine)Cl]Cl, does not form N7,N7-d(GpG) chelates with DNA. An unexpected preference for platinum binding at the 5'G in d(GpG).
Lempers EL; Bloemink MJ; Brouwer J; Kidani Y; Reedijk J
J Inorg Biochem; 1990 Sep; 40(1):23-35. PubMed ID: 2283508
[TBL] [Abstract][Full Text] [Related]
35. Preparation and characterization of platinum(II) and (IV) complexes of 1,3-diaminepropane and 1,4-diaminebutane: circumvention of cisplatin resistance and DNA interstrand cross-link formation in CH1cisR ovarian tumor cells.
Alvarez-Valdés A; Pérez JM; López-Solera I; Lannegrand R; Continente JM; Amo-Ochoa P; Camazón MJ; Solans X; Font-Bardía M; Navarro-Ranninger C
J Med Chem; 2002 Apr; 45(9):1835-44. PubMed ID: 11960495
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.
Knox RJ; Friedlos F; Lydall DA; Roberts JJ
Cancer Res; 1986 Apr; 46(4 Pt 2):1972-9. PubMed ID: 3512077
[TBL] [Abstract][Full Text] [Related]
37. Exploring the DNA binding/cleavage, cellular accumulation and topoisomerase inhibition of 2-hydroxy-3-(aminomethyl)-1,4-naphthoquinone Mannich bases and their platinum(II) complexes.
Neves AP; Pereira MX; Peterson EJ; Kipping R; Vargas MD; Silva FP; Carneiro JW; Farrell NP
J Inorg Biochem; 2013 Feb; 119():54-64. PubMed ID: 23186648
[TBL] [Abstract][Full Text] [Related]
38. Energetics, conformation, and recognition of DNA duplexes containing a major adduct of an anticancer azolato-bridged dinuclear Pt(II) complex.
Mlcouskova J; Malina J; Novohradsky V; Kasparkova J; Komeda S; Brabec V
Biochim Biophys Acta; 2012 Oct; 1820(10):1502-11. PubMed ID: 22683702
[TBL] [Abstract][Full Text] [Related]
39. One-milliliter wet-digestion for inductively coupled plasma mass spectrometry (ICP-MS): determination of platinum-DNA adducts in cells treated with platinum(II) complexes.
Yamada K; Kato N; Takagi A; Koi M; Hemmi H
Anal Bioanal Chem; 2005 Aug; 382(7):1702-7. PubMed ID: 15959768
[TBL] [Abstract][Full Text] [Related]
40. Diazido mixed-amine platinum(IV) anticancer complexes activatable by visible-light form novel DNA adducts.
Zhao Y; Woods JA; Farrer NJ; Robinson KS; Pracharova J; Kasparkova J; Novakova O; Li H; Salassa L; Pizarro AM; Clarkson GJ; Song L; Brabec V; Sadler PJ
Chemistry; 2013 Jul; 19(29):9578-91. PubMed ID: 23733242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]